Navigation Links
Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease
Date:11/12/2008

MIAMI, Nov. 12 /PRNewswire/ -- The Miami Jewish Home and Hospital, Berma Research Group, and Segal Institute for Clinical Research today announced that they are actively enrolling patients in the CONNECTION study, a Phase 3 clinical trial that is evaluating the safety and efficacy of the investigational drug Dimebon as a treatment for mild-to-moderate Alzheimer's disease.

According to new estimates from the Alzheimer's Association, more than 5 million people in the United States are living with Alzheimer's disease, a progressive, debilitating and deadly disease that destroys brain cells and affects areas of the brain involved in memory, cognition, judgment, language and behavior. As the baby boomer population ages, the incidence of Alzheimer's disease is expected to increase dramatically. Currently available therapies for Alzheimer's treat the symptoms with modest effect, and there is no evidence that these medications alter the course of the underlying disease process.

"New therapies are urgently needed to more effectively treat the symptoms of Alzheimer's disease," said Dr. Marc Agronin, director of mental health services at the Miami Jewish Home and Hospital and associate professor of psychiatry at the University of Miami Miller School of Medicine. "Results from a previous study of Dimebon in Alzheimer's disease were encouraging, and we look forward to further assessing Dimebon's promise in the fight against Alzheimer's disease in the CONNECTION study. We encourage local patients and caregivers to learn more about this trial."

About Dimebon

Dimebon is an investigational therapy in clinical development for the treatment of Alzheimer's disease. It targets Alzheimer's disease differently than currently available therapies. Mitochondria (a cell's primary source of energy) are the target of Dimebon's mechanism of action.

Medivation, Inc., the company developing Dimebon and sponsoring the CONNECTION study, previously announced
'/>"/>

SOURCE Miami Jewish Home & Hospital; Berma Research Group; SegalInstitute
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
2. Miami Plastic Surgeon Offers Hope to Acne Scarred Patients
3. Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in Miami
4. National Jewish Health and Roche Diagnostics Corporation Reach Agreement to Pursue Environmental Molecular Diagnostics Opportunities
5. National Jewish, Brigham and Womens Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
6. Sarah Cannon Research Institute Selects OmniComm Systems Electronic Data Capture Solution, TrialMaster(TM), for Clinical Trials Management
7. Michael J. Fox Foundation Announces $11 Million in 2009 Funding for Translational, Pre-Clinical and Clinical Parkinsons Disease Research
8. SELECT TRIAL Used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R) - Previous Research has Shown SelenoExcell(R) Supplementation to Reduce Lung, Colon and Prostate Cancers by as Much as 63%, Says Cypress Systems, Inc.
9. Premier Research Honored as Clinical Research Team of the Year at 2008 GCPj Awards
10. Nuvo Research presents positive Phase III study results for Pennsaid at leading rheumatology conference
11. Alzheimers Association Grant Furthers Successful Research at UMass Lowell

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...mpraPharmaceuticalsInc.todayannouncedthatPrabhavat...presentatthePiperJaffray21stAnnualHealthCareConfer...eHotelinNewYorkCity.Dr.Fernandeswillprovideanoverv...amsforthetreatmentofdrug-resistantpathogensincludi...oundedin2006,CempraPharmaceuticalsisaprivately-hel...
(Date:11/25/2009)...-- ChemoCentryx,Inc.,announcedtodaythatPhaseII/II...iveRandomizedOralTherapyEvaluationinCrohn,sdisease...erate-to-severeCrohn,sdiseasedemonstratedclinicale...Thestudydemonstratedevidenceofclinicalefficacyinth...reaseintheCrohn,sDiseaseActivityIndex(CDAI)inpatie...
(Date:11/24/2009)...Call/--Vermillion,Inc.(VRML)(PinkSheets:VRMLQ)anno...losureStatementtoday,November24,2009,withtheUnited...ringtoconsiderapprovaloftheDisclosureStatementispr...theconfirmationofthePlanscheduledforJanuary7,2010....ll.ThePlanisexpected,ifapproved,toallowholdersofth...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Strategic Information Group Announces QAD Enterprise Validation Partnership 58107 1Strategic Information Group Announces QAD Enterprise Validation Partnership 58107 2Strategic Information Group Announces QAD Enterprise Validation Partnership 58107 3John Legend and Noah G POP Lend Their Talents for Kids 58103 1Monarch Labs to Demonstrate Maggot Therapy at Diabetic Limb Salvage Conference 58099 1Monarch Labs to Demonstrate Maggot Therapy at Diabetic Limb Salvage Conference 58099 2Monarch Labs to Demonstrate Maggot Therapy at Diabetic Limb Salvage Conference 58099 3
...ne 4 BN,ImmunoTherapeutics, Inc. has initiated Ph...cine candidate against prostate cancer., A Phase ...ents with,non-metastatic as well as hormone-insens...S. Secondary objectives of the trial include exami... antigen-specific immune,responses, as well as cli...
...Molecular Vision -, - Results Show Good Distribut... after a Single Intravitreal Injection -, ...ay announced that a study published in the peer-re...bevasiranib, its siRNA (small,interfering RNA) age...tensive uptake into the retina. In two tissue dist...
Other Medicine Technology:BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine 2Newly Published Study Shows OPKO's siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye 2Newly Published Study Shows OPKO's siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye 3
(Date:11/26/2009)... Research Triangle Dental (RTDental), a leadin... today announced the expansion of its services to ... Dr. Doug Macmillan. , ... pleased to announce that Dr. Doug Macmillan, an e... an additional advanced training seminar. RTDenta...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free nati... and Yasmin birth control pills who have suffered ...Stroke, Heart Attack or other related cardiac issu...l toll free at 1-800-856-6405 or go to the firm&rs...l out an online case evaluation form. , ...
(Date:11/25/2009)....,Nov.25/PRNewswire/--TheBartleHallConventionCente...niconDec.9-10,whenKansasCityhoststhelatestinaserie...isfreecliniceventhasthepotentialtobethebiggestoney...ndbeheldonweekdaysinsteadofoveraweekend,"SheriWood...ndpresidentoftheNationalAssociationofFreeClinics(N...
(Date:11/25/2009)...GARY,Nov.25/PRNewswire/-SentinelleMedicalInc.,alea...lsandsoftwareandCalgaryScientificInc.,aleadingprov...webversionofAegis(TM)Breast4DAdvancedVisualization...rulyzero-footprintWebclientbasedmedicalimagingoffe...formallowsforzero-footprintaccess-requiringnosoftw...
(Date:11/25/2009)...if.,Nov.25/PRNewswire/--Thanksgivingmealswillbedel...aterLongBeachareathankstoFaithInAction/VolunteerAc...IAH),adivisionofSCANHealthPlan.Formorethan17yearst...odeliverwarmThanksgivingmealstoseniorsinneedinLong...andsurroundingcities. ,, "Ourwarmholidaymealsar...
Breaking Medicine News(10 mins):Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2
...d States – A novel insight has revealed that most ...gery as a treatment, rather than a non-invasive re...radual, non-aggressive prostate cancer, less than ...ts who suffered low-risk prostate cancer. Am...
...velyn Shatil from The Center for Brain Research an... the Department of Psychology// at the University ...entifying and diagnosing learning disabilities. .... The test diagnoses reading and writing disabilit...
...tein known for its ability to “bridge” interaction...sis in breast cancer//, the disease’s deadliest st...search has found. Led by professor Gen-Sheng...cancer role for the protein known as Gab-2. These ...
...if you're fine, you should not forget to watch you...ic stroke, doctors// in Boston tell healthy women....ubstance found among lipids in the bloodstream) in...edical School, Boston, and other researchers studi...
...kers looking to force preteen girls to take Gardas...ical cancer, are targeting// the wrong age group, ...ulated with the breakthrough vaccine will be no ol...exually transmitted human papillomavirus (HPV). ...
...h officials across UK are participating in a dummy...t// by bird flu pandemic. The preparation may...rts in Britain are wary of a bird flu epidemic hit...found chiefly in birds, but infections with these ...
Other Medicine News:Health News:Standardized Diagnostic Test for Learning Disabilities 2Health News:“Bridge” Protein Spurs Deadliest Stages of Breast Canc 2Health News:Cancer-virus Vaccine Targets Wrong Age Group 2Health News:Dummy Emergency Operation Launched 2
The Carpal Solution
...mometer that measures temperatures from -50 to 200...splay and minimum/maximum temperature memory. The ...ally, with adhesive, by keyhole or flip-out desk s...accurate to within 1C from -50 to 120C and within ...
...ic pipets without purchasing equipment or interrup...ix vials of Receiver Solution and one or two vial(...or to be verified, the technologist performs six s...ck for analysis and calculation of the results. Wi...
...a sheath fluid when performing analysis by flow cy... dilutes to 3L of sheath fluid with distilled wate...ntrate reduces heavy lifting, increases usable spa...e. Streck Cytometry Concentrate has a closed-vial ...
Medicine Products: